China Nuokang Bio-Pharma, a leading provider of blood-clotting medication in China, will see its quiet period end next Monday, Jan. 18. On Dec. 9, 2009, the company raised $45 million by offering 5 million shares at $9 each, below the range of $10-$12. Jefferies acted as the lead manager on the deal.
